AMPLATZER Duct Occluder II Clinical Study

NACompletedINTERVENTIONAL
Enrollment

192

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

October 31, 2011

Study Completion Date

October 5, 2016

Conditions
Patent Ductus Arteriosus
Interventions
DEVICE

AMPLATZER Duct Occluder II

AMPLATZER Duct Occluder II

Trial Locations (25)

10029

Mount Sinai School of Medicine, New York

10467

The Children's Hospital Montefiore, The Bronx

19803

Alfred I. DuPont Hospital for Children -Nemours Cardiac Center, Wilmington

20010

Children's National Medical Center, Washington D.C.

29425

Medical University of South Carolina, Charleston

30322

Children's Healthcare of Atlanta, Atlanta

33021

Memorial Regional Hospital (Joe DiMaggio Children's Hospital), Hollywood

43205

Nationwide Children's Hospital, Columbus

44195

The Children's Hospital at Cleveland Clinic, Cleveland

46202

Riley Hospital for Children, Indianapolis

53226

Children's Hospital of Wisconsin, Milwaukee

55455

University of Minnesota, Minneapolis

63110

Washington University School of Medicine, St Louis

75235

University of Texas SW Medical Center, Dallas

80045

The Children's Hospital - Denver, Aurora

84113

Primary Children's Medical Center, Salt Lake City

92123

Children's Hospital and Health Center, San Diego

94143-0544

University of California San Francisco Hospital, San Francisco

02115

Children's Hospital Boston, Boston

39216-4505

University of Mississippi Medical Center, Jackson

45229-3039

Cincinnati Children's Hospital Medical Center, Cincinnati

19104-4399

The Children's Hospital of Philadelphia, Philadelphia

37232-9119

Vanderbilt Children's Hospital, Nashville

77030-2399

Texas Children's Hospital, Houston

98105-0371

Children's Hospital and Regional Medical Center, Seattle

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT00713700 - AMPLATZER Duct Occluder II Clinical Study | Biotech Hunter | Biotech Hunter